Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Clinical trial NCT01954251 · COMPLETED
Trial details
- NCT number
- NCT01954251
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-03
- Primary completion
- 2014-06-02
- Enrollment
- 829
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.